Literature DB >> 35036041

Photobiocatalytic Oxyfunctionalization with High Reaction Rate using a Baeyer-Villiger Monooxygenase from Burkholderia xenovorans in Metabolically Engineered Cyanobacteria.

Elif Erdem1,2, Lenny Malihan-Yap1, Leen Assil-Companioni1,3, Hanna Grimm1, Giovanni Davide Barone1,4,5, Carole Serveau-Avesque2, Agnes Amouric2, Katia Duquesne2, Véronique de Berardinis6, Yagut Allahverdiyeva7, Véronique Alphand2, Robert Kourist1,3.   

Abstract

Baeyer-Villiger monooxygenases (BVMOs) catalyze the oxidation of ketones to lactones under very mild reaction conditions. This enzymatic route is hindered by the requirement of a stoichiometric supply of auxiliary substrates for cofactor recycling and difficulties with supplying the necessary oxygen. The recombinant production of BVMO in cyanobacteria allows the substitution of auxiliary organic cosubstrates with water as an electron donor and the utilization of oxygen generated by photosynthetic water splitting. Herein, we report the identification of a BVMO from Burkholderia xenovorans (BVMO Xeno ) that exhibits higher reaction rates in comparison to currently identified BVMOs. We report a 10-fold increase in specific activity in comparison to cyclohexanone monooxygenase (CHMO Acineto ) in Synechocystis sp. PCC 6803 (25 vs 2.3 U gDCW -1 at an optical density of OD750 = 10) and an initial rate of 3.7 ± 0.2 mM h-1. While the cells containing CHMO Acineto showed a considerable reduction of cyclohexanone to cyclohexanol, this unwanted side reaction was almost completely suppressed for BVMO Xeno , which was attributed to the much faster lactone formation and a 10-fold lower K M value of BVMO Xeno toward cyclohexanone. Furthermore, the whole-cell catalyst showed outstanding stereoselectivity. These results show that, despite the self-shading of the cells, high specific activities can be obtained at elevated cell densities and even further increased through manipulation of the photosynthetic electron transport chain (PETC). The obtained rates of up to 3.7 mM h-1 underline the usefulness of oxygenic cyanobacteria as a chassis for enzymatic oxidation reactions. The photosynthetic oxygen evolution can contribute to alleviating the highly problematic oxygen mass-transfer limitation of oxygen-dependent enzymatic processes.
© 2021 The Authors. Published by American Chemical Society.

Entities:  

Year:  2021        PMID: 35036041      PMCID: PMC8751089          DOI: 10.1021/acscatal.1c04555

Source DB:  PubMed          Journal:  ACS Catal            Impact factor:   13.084


C–H oxyfunctionalization belongs to the most important class of organic transformations. With their often outstanding selectivity and capacity for the selective functionalization of hydrocarbons, oxygenases have assumed an important role in synthetic chemistry.[1] Yet, despite their wide availability and diversity in nature, the difficulty in supplying sufficient oxygen for the reaction has, thus far, hindered the broad applications of mono- and dioxygenases. Developing enzymatic systems to establish biocatalytic processes for the production of bulk chemicals is one of the main challenges for biocatalysis; ε-caprolactone (1b), for example, is a precursor for the synthesis of polycaprolactone and produced at a multi-10000 ton scale per year via the UCC process.[2] This process, which involves the oxidation of cyclohexanone using peracetic acid in stoichiometric amounts, results in a high amount of toxic side products. In contrast, Baeyer–Villiger monooxygenases (BVMO) allow for mild reaction conditions for the synthesis of various lactones and have received considerable attention as catalysts for the synthesis of important heterocyclic bulk chemicals (Scheme ).[3,4]
Scheme 1

Photosynthesis-Driven Lactone Synthesis (b) and Native Alcohol Dehydrogenase Driven Ketoreduction (c) in Synechocystis sp. PCC 6803

The application of these enzymes on a larger scale has, thus far, been limited due to several factors; among them is the aforementioned difficulty in supplying sufficient oxygen for the reaction. Evidently, Baldwin et al. previously demonstrated that whole-cell biotransformations using BVMOs are oxygen-limited at cell concentrations as low as 2 gDCW L–1.[5,6] Furthermore, the stoichiometric addition of an auxiliary molecule for cofactor regeneration is necessary, which severely reduces the atom economy of the process.[7] In a heterotrophic cell, the most common chassis for BVMOs, a considerable part of the nicotinamide cofactors are diverted toward respiration which, therefore, renders it as an additional oxygen sink. To this end, the use of photosynthetic cyanobacteria, which use photosynthetic water splitting for both oxygen evolution and the regeneration of redox cofactors, as hosts is advantageous[8] (Scheme ). As typical photosynthetic net oxygen evolution rates of cyanobacteria lie in the range of 1–2 μmol O2 mgchl–1 min–1, there should be sufficient oxygen available for oxyfunctionalization reactions.[8−10] We previously reported that whole-cell biotransformations in recombinant Synechocystis sp. PCC 6803 (hereafter Synechocystis or Syn) expressing the cyclohexanone monooxygenase from Acinetobacter sp. (CHMO) under the control of a light-inducible promoter, P, exhibited reaction rates of 2–5 U gDCW–1.[11] This represents a 10-fold lower rate in comparison to those obtained with other recombinant enzymes in the same organism.[12−15] Moreover, the reduction of cyclic ketones by endogenous alcohol dehydrogenases (ADH) competes with the Baeyer–Villiger oxidation, which is especially problematic considering that cyclohexanol (1c) inhibits CHMO.[16] Herein, we pursue an integrated approach combining enzyme discovery, promoter engineering, and redesigning of the photosynthetic electron transport chain (PETC) to increase the specific activity of BVMOs in cyanobacteria and to reduce the undesired ketoreduction. To identify a BVMO with reaction rates in Synechocystis superior to that with CHMO,[11] we expressed the genes of a panel of monooxygenases selected from a previous high-throughput cloning[17] in E. coli and screened them via whole-cell oxidation of cyclohexanone (1a). Figure shows the whole-cell biotransformation of 1a mediated by several BVMOs expressed in E. coli. While 9 out of the 11 enzymes tested had a much lower specific activity in comparison to CHMO, we noted that a BVMO from Burkholderia xenovorans (BVMO) exhibited a higher specific rate of 19 ± 2.0 U gDCW–1 in E. coli (Figure C). This represents a ∼48% faster rate in comparison to those achieved with CHMO (13 U gDCW–1). BVMO belongs to the strictly NADPH dependent type I family of BVMO and has 39% identity with CHMO. Moreover, it shows the typical signature motif of type I BVMOs ([A/G]GxWxxxx[F/Y]P[G/M]-xxxD) (Figure S3).[18]
Figure 1

Whole-cell biotransformation of 1a mediated by (A) BVMO and (B) CHMO in E. coli BL21(DE3). (C) Specific activities of various BVMOs in recombinant E. coli cells producing 1b. Reaction conditions: 30 mL, 25 °C, 200 rpm, initial concentration of 5 mM 1a, N = 3 independent repetitions. Error bars represent standard deviations.

Whole-cell biotransformation of 1a mediated by (A) BVMO and (B) CHMO in E. coli BL21(DE3). (C) Specific activities of various BVMOs in recombinant E. coli cells producing 1b. Reaction conditions: 30 mL, 25 °C, 200 rpm, initial concentration of 5 mM 1a, N = 3 independent repetitions. Error bars represent standard deviations. Figure shows the optimum pH and temperature of BVMO as well as its substrate scope. The substrate scope of BVMO is similar to that of the other type 1 BVMOs with higher activity toward cyclohexanone derivates, and the pH spectrum is typical of bacterial BVMOs. However, BVMO has optimal activity at pH 8, while the optimum activity of CHMO lies at pH 9.[19] This could be an important advantage for the application in Synechocystis with an intracellular pH value of 7.[20] We noted that the initial rates obtained at elevated temperatures were relatively high, with the highest rates obtained at 40 °C. This is an unusual observation for BVMOs in cell-free systems. Moreover, BVMO showed in the ThermoFAD method[21] in sodium phosphate buffer at pH 7.5 an unfolding temperature of 37.6 ± 0.1 °C in comparison to CHMO with 35.6 ± 0.1 °C, which is another indication of a higher stability (Table S3). Table gives a comparison of the kinetic parameters of BVMO and CHMO from the conversion of 1a. We note that the catalytic efficiency of the former is higher. This is based on a 10-fold lower KM value, whereas the specific activity is much lower. While the low stability of CHMO in cell-free systems has been known for a long time, Rudroff and co-workers reported the surprising discovery that E. coli is not capable of providing sufficient cofactor for a stable maintenance of the enzyme, leading to a very poor stability also in the whole-cell system.[22] Moreover, a visual comparison of the enzyme production in SDS-PAGE indicated a slightly better production of BVMO (Figure S4). It remains unclear if the higher activity of BVMO in E. coli cells may be attributed either to the much lower KM value (with the efficient substrate concentration within cells being unknown) or to a higher stability of BVMO. Nevertheless, the result obtained in the whole-cell system presented this new BVMO as an ideal candidate to achieve higher reaction rates in cyanobacteria.
Figure 2

Characterization of BVMO: effect of (A) pH and (B) temperature on its activity; (C) substrate scope. Data stemmed from the purified enzyme which were measured and calculated from the NADPH consumption during the reaction with 1 mM of substrate. The relative activities were calculated in correlation with the reactions of 1 mM cyclohexanone. N = 3 independent repetitions. Error bars represent standard deviationa.

Table 1

Kinetic Parameters of BVMO and CHMOa

paramBVMOXenoCHMOAcineto
KM (μM)22.7 ± 5266.6 ± 25.5
kcat (min–1)103.0 ± 3.0272.4 ± 5.7
kcat/KM (μM min–1)4.6 ± 0.71.02 ± 0.1
specific activity (μmol min–1 mg–1)1.7 ± 0.18.8 ± 0.2

Experimental conditions: 50 mM Tris-HCl, pH 8, 25 °C (see the Supporting Information for details).

Experimental conditions: 50 mM Tris-HCl, pH 8, 25 °C (see the Supporting Information for details). Characterization of BVMO: effect of (A) pH and (B) temperature on its activity; (C) substrate scope. Data stemmed from the purified enzyme which were measured and calculated from the NADPH consumption during the reaction with 1 mM of substrate. The relative activities were calculated in correlation with the reactions of 1 mM cyclohexanone. N = 3 independent repetitions. Error bars represent standard deviationa. Synechocystis cells producing BVMO under the promoter P showed an activity of <1 U gDCW–1 (Figure S8), which is comparable to our previous results obtained with the same cells harboring CHMO.[11] Previously, we demonstrated that the recombinant production of oxidoreductases in Synechocystis, such as ene-reductases[14] and BVMOs,[11] greatly increased reaction rates surpassing the native ketoreduction rates previously reported using wild-type cyanobacteria.[23−28] Indeed, photobiotransformations have found application in diverse reactions, including the hydroxylation of hydrocarbons[12,15] and synthesis of chiral amines by imine reductases, showing the versatility of the approach.[13] While we had utilized the light-inducible promoter P in our previous work, the stronger light-regulated promoter P[29,30] led to higher specific activities with other oxidoreductases in Synechocystis, thereby outcompeting the native ADHs and reducing resultant ketoreduction rates.[13,31] This homologous promoter controls the cpc operon that encodes for a photosynthesis antenna protein, phycocyanin, and is one of the strongest promoters known for Synechocystis.[29,30] Therefore, we cloned both bvmo genes under the control of this promoter and expressed the resulting strain under a constant light regimen. Syn::PcpcCHMO showed a specific activity of 4 U gDCW–1 in the oxidation of 1a and 0.53 U gDCW–1 in its ketoreduction. We were pleased to find that with the same promoter, Syn::PBVMO, had a much higher specific activity of 18 ± 3 U gDCW–1 at a cell density of 2.4 g L–1 (Figure A,B) and an activity of 0.30 U gDCW–1 in the ketoreduction. With an initial product formation of 2.7 ± 0.4 mM h–1, the reaction proceeded to completion within 3 h, as shown in Figure A. This represented an almost 10-fold improvement in comparison to our previous work on CHMO under the control of P, which had a specific activity of 2.3 ± 0.05 U gDCW–1 toward 1a.[11] Due to the lower activity in the ketoreduction, the formation of 1c with Syn::PBVMO was greatly reduced (1.6% after 3 h) and remained constant in comparison to our previous results with Syn::PCHMO. In the case of a branching metabolic pathway, where two enzymes or two groups of enzymes compete for a substrate S, the ratio of the total activities will depend (in case of low substrate saturation) on the total enzyme concentrations and the catalytic efficiencies.[32]
Figure 3

Whole-cell biotransformation of 1a in Synechocystis harboring BVMO and BVMO. Time course of product formation and substrate consumption by (A) Syn::PBVMO and (D) Syn::PBVMO and their corresponding ΔFlv1 mutants (depicted as dashed lines). Specific whole-cell activities relative to cell dry weight (2.4 gDCW L–1) of Synechocystis harboring (B) BVMO and (E) BVMO and their corresponding ΔFlv1 mutants. Activity calculations were performed in the presence of ≤10% product. The rate of the product formation is depicted as a blue circle. (C) Intracellular BVMO activity in the oxidation of 1a using Syn::PBVMO and ΔFlv1::PBVMO. (F) Product distributions after 3 h of reaction using BVMO and BVMO. Reaction conditions: 1 mL, 30 °C, 160 rpm, initial concentration 10 mM of 1a, light intensity of 300 μE m–2 s–1, N = 3 independent repetitions. Error bars represent standard deviations. P values were calculated using Welch’s t test (*P < 0.05) and correspond to the specific activity comparison between BVMO and BVMO and their corresponding ΔFlv1 mutants.

Whole-cell biotransformation of 1a in Synechocystis harboring BVMO and BVMO. Time course of product formation and substrate consumption by (A) Syn::PBVMO and (D) Syn::PBVMO and their corresponding ΔFlv1 mutants (depicted as dashed lines). Specific whole-cell activities relative to cell dry weight (2.4 gDCW L–1) of Synechocystis harboring (B) BVMO and (E) BVMO and their corresponding ΔFlv1 mutants. Activity calculations were performed in the presence of ≤10% product. The rate of the product formation is depicted as a blue circle. (C) Intracellular BVMO activity in the oxidation of 1a using Syn::PBVMO and ΔFlv1::PBVMO. (F) Product distributions after 3 h of reaction using BVMO and BVMO. Reaction conditions: 1 mL, 30 °C, 160 rpm, initial concentration 10 mM of 1a, light intensity of 300 μE m–2 s–1, N = 3 independent repetitions. Error bars represent standard deviations. P values were calculated using Welch’s t test (*P < 0.05) and correspond to the specific activity comparison between BVMO and BVMO and their corresponding ΔFlv1 mutants. The Baeyer–Villiger monooxygenase and the alcohol dehydrogenase compete for the substrate. Since the dehydrogenase parameters are strain-dependent, they can be considered as constant and the KM value of the BVMO appears as a crucial parameter for the observed selectivity. In light of this, a 10-fold lower KM value of BVMO toward 1a is therefore highly important to suppress the unwanted alcohol formation. As Syn::PBVMO showed only minimal ketoreduction, inhibition by this side product was ruled out as the rate-limiting factor for this biocatalyst. However, the reaction product 1b might also exert an inhibitory effect. To study this, we performed whole-cell biotransformation reactions in the presence of different concentrations of 1b. Indeed, the activity of the cells was decreased by 50% in the presence of 10 mM 1b (Figure S9), which slows down the reaction in the later phases of the process but basically results only in a moderate extension of the reaction time. To study the enantiospecificity of the whole-cell biocatalyst, we investigated the kinetic resolution of racemic 2-phenylcyclohexanone (2a), which was converted with outstanding enantiospecificity (E > 200, Figure S6), leading to the formation of the “normal” lactone (R)-7-phenyloxepan-2-one (2b) in very high optical purity (99% ee). Formation of the “abnormal” lactone or the undesired ketoreduction was not observed. The high selectivity demonstrates the practical value of the method for the synthesis of optically pure ketone and lactones. In an attempt to increase the activity further, we investigated BVMO in a Synechocystis mutant with a disrupted electron valve; namely, the Flv1/3 heterodimer. The regulation of photosynthetic light reactions, which produce ATP and key cofactors such as NADPH and ferredoxin, is crucial for the maintenance of redox balance within a photosynthetic organism such as Synechocystis. Alternative electron flow (AEF) actively partakes in this crucial process and can confer protection against various environmental stressors in the natural habitat of cyanobacteria. These routes, which alleviate excessive reduction of the photosynthetic electron and balance the intracellular ATP/NADPH ratio, may be dispensable under controlled conditions which, in turn, can broaden access to key cofactors via heterologous electron sinks.[33] Naturally occurring flavodiiron proteins (FDPs) in Synechocystis act as an efficient release valve for excess electrons, reducing O2 to H2O. Although the Flv1 and Flv3 proteins have previously been shown to be crucial for survival under fluctuating light conditions,[34] we have previously shown that, through their disruption, the activity of an NADPH-limited heterologous ene-reductase could be substantially improved at cell densities where light fluctuations are expected.[31] Herein, we sought to expand the realm of possible reactions that can be enhanced using this approach to include oxyfunctionalizations by BVMOs. Indeed, whole-cell biotransformations conducted in ΔFlv1 background strains had a 1.4-fold increased activity of 25.7 ± 1.2 U gDCW–1. With a product formation rate of 3.7 ± 0.2 mM h–1, the reaction proceeded to completion in less than 3 h (Figure A). Notably, cell-free extracts of Syn::PBVMO and ΔFlv1::PBVMO did not show significantly different rates in the Baeyer–Villiger oxidation of 1a, confirming that the observed effect is not due to a higher production of the enzyme but is indeed a result of the Flv1 deletion (Figure C). In order to test the robustness of the improved ΔFlv1 activities, we expressed the gene of a second BVMO from Parvibaculum lavamentivorans DSM 1302332 (BVMO) and tested its activity during whole-cell biotransformations. Figure D shows the whole-cell biotransformation of 1a mediated by Syn::PBVMO and its ΔFlv1 variant, ΔFlv1::PBVMO. Similar to results obtained with ΔFlv1::PBVMO, a 1.6-fold increase in activity was observed with ΔFlv1::PBVMO (Figure E). BVMO, which showed an activity in the range of other BVMOs (Figure C), served as a good example that rational re-engineering of the PETC can improve the activities of slower BVMOs as well. Interestingly, the rate increase also reduced the formation of 1c from 12.5% to 7.5%. In the case of the faster reaction with BVMO, the use of the ΔFlv1 mutant did not lead to any further decrease of the already low formation of 1.5% 1c after 3 h (Figure F). In conclusion, our results underline the extent to which careful selection of a candidate BVMO can help to improve reaction rates and highlight the potential of photosynthetic cofactor regeneration for enzymatic oxyfunctionalization reactions. A possible reason for the better whole-cell activity is the higher stability of BVMO in comparison to CHMO, indicated by a higher degradation temperature and activity at higher temperatures. Furthermore, the optimal pH of 8 is closer to the intracellular pH value in comparison to the optimal pH of CHMO at pH 9, which presumably has consequences for the functional stability of the enzyme. Finally, the much lower KM value of BVMO is important to achieve a higher selectivity for the Baeyer–Villiger oxidation over the ketoreduction and to almost completely suppress this unwanted side reaction. Overall, the specific activities we obtained underscore the fact that oxygen-producing photoautotrophs can compete with oxygen-consuming heterotrophs as host organisms for biotransformations. Additionally, the rational engineering of the PETC in these organisms can serve to improve overall activities that exceed those obtained with E. coli at a cell density where the oxygen supply becomes limiting for this organism. After the successful rate increase by enzyme discovery, promoter, and metabolic engineering, our future research will be directed toward the intensification of the light-driven Baeyer–Villiger oxidation. Here, photobioreactors using the principle of internal illumination present themselves as a highly promising solution in order to alleviate the cell density limitation of cyanobacterial biocatalysts.[35,36]
  24 in total

1.  Thymine at -5 is crucial for cpc promoter activity of Synechocystis sp. strain PCC 6714.

Authors:  Masahiko Imashimizu; Shoko Fujiwara; Ryohei Tanigawa; Kan Tanaka; Takatsugu Hirokawa; Yuji Nakajima; Junichi Higo; Mikio Tsuzuki
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

2.  ThermoFAD, a Thermofluor-adapted flavin ad hoc detection system for protein folding and ligand binding.

Authors:  Federico Forneris; Roberto Orru; Daniele Bonivento; Laurent R Chiarelli; Andrea Mattevi
Journal:  FEBS J       Date:  2009-05       Impact factor: 5.542

3.  Flavodiiron proteins Flv1 and Flv3 enable cyanobacterial growth and photosynthesis under fluctuating light.

Authors:  Yagut Allahverdiyeva; Henna Mustila; Maria Ermakova; Luca Bersanini; Pierre Richaud; Ghada Ajlani; Natalia Battchikova; Laurent Cournac; Eva-Mari Aro
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

4.  Regulation of reaction fluxes via enzyme sequestration and co-clustering.

Authors:  Florian Hinzpeter; Filipe Tostevin; Ulrich Gerland
Journal:  J R Soc Interface       Date:  2019-07-31       Impact factor: 4.118

5.  Regulatory electron transport pathways of photosynthesis in cyanobacteria and microalgae: Recent advances and biotechnological prospects.

Authors:  Lauri Nikkanen; Daniel Solymosi; Martina Jokel; Yagut Allahverdiyeva
Journal:  Physiol Plant       Date:  2021-03-25       Impact factor: 4.500

6.  Light-Dependent and Aeration-Independent Gram-Scale Hydroxylation of Cyclohexane to Cyclohexanol by CYP450 Harboring Synechocystis sp. PCC 6803.

Authors:  Anna Hoschek; Jörg Toepel; Adrian Hochkeppel; Rohan Karande; Bruno Bühler; Andreas Schmid
Journal:  Biotechnol J       Date:  2019-06-18       Impact factor: 4.677

7.  Tuning of the enzyme ratio in a neutral redox convergent cascade: A key approach for an efficient one-pot/two-step biocatalytic whole-cell system.

Authors:  Sidiky Ménil; Jean-Louis Petit; Elise Courvoisier-Dezord; Adrien Debard; Virginie Pellouin; Thomas Reignier; Michelle Sergent; Valérie Deyris; Katia Duquesne; Véronique de Berardinis; Véronique Alphand
Journal:  Biotechnol Bioeng       Date:  2019-09-03       Impact factor: 4.530

8.  Inactivation of Ca(2+)/H(+) exchanger in Synechocystis sp. strain PCC 6803 promotes cyanobacterial calcification by upregulating CO(2)-concentrating mechanisms.

Authors:  Hai-Bo Jiang; Hui-Min Cheng; Kun-Shan Gao; Bao-Sheng Qiu
Journal:  Appl Environ Microbiol       Date:  2013-04-26       Impact factor: 4.792

9.  An enzyme cascade synthesis of ε-caprolactone and its oligomers.

Authors:  Sandy Schmidt; Christian Scherkus; Jan Muschiol; Ulf Menyes; Till Winkler; Werner Hummel; Harald Gröger; Andreas Liese; Hans-Georg Herz; Uwe T Bornscheuer
Journal:  Angew Chem Int Ed Engl       Date:  2015-01-19       Impact factor: 15.336

10.  Recombinant Cyanobacteria for the Asymmetric Reduction of C=C Bonds Fueled by the Biocatalytic Oxidation of Water.

Authors:  Katharina Köninger; Álvaro Gómez Baraibar; Carolin Mügge; Caroline E Paul; Frank Hollmann; Marc M Nowaczyk; Robert Kourist
Journal:  Angew Chem Int Ed Engl       Date:  2016-03-29       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.